In our experimental model, weekly injection of 25 IU/kg rFVIII led to the development of anti-FVIII antibodies in all previously untreated hemophilia A mice that continued to increase in titer until the end of the experiment (week 12), in agreement with published data16,32 (Fig. 2). The gene discussed is F8; the disease is hemophilia A.